| Inventor | Institute |
|---|---|
| Akira Ono | University of Michigan |
| SKU: | 156505 |
|---|---|
| Product description: | Human lymphatic fibroblasts were immortalized by transfecting them with a vector that expresses HPV16 E6 and E7 genes. Primary fibroblastic reticular cells (FRCs) are stromal cells found in secondary lymphoid organs, which are major sites for HIV-1 infection of CD4+ T cells. Using the immortalized FRCs it was shown that FRCs capture HIV-1 particles and facilitate infection of T cells when FRCs contact T cells, increasing HIV-1 spread via trans-infection. |
| Production details: | Immortalized Human lymphatic fibroblasts were generated by transfection of cells with vector pLXSN16E6E7, which encodes HPV E6 and E7, and subsequent selection in fibroblast growth supplement containing G418. A clone was isolated from G418-resistant cells by limiting dilution and cultured in fibroblast growth supplement without G418. |
| Parental cell line: | Human lymphatic fibroblasts |
| Cat. #: | 156505 |
|---|---|
| Unit size: | 1×10^6 cells / vial |
| Research Fields: | Immunology |
| Organism: | Human |
| Tissue: | Lymph Node |
| Model: | Immortalised Line |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | Fibroblast Medium (FM, 2% FBS) — ScienCell, Cat# 2301 Note: The term “FM-2” used in the original publication refers to Fibroblast medium containing 2% FBS (ScienCell Cat# 2301) |
| Subculture routine: | Seed cells at 80000/ ml or 16000/cm2. Split every 2-3 days, maintain for up to two months post-revival of frozen cells. Please also see detailed protocol within the Product Datasheet in the Documentation section below. |
| Temperature: | 37°C |
| Atmosphere: | 5% CO2 |
| References: |
Murakami et al. 2018. Nat Commun. 22:9(1):2436. PMID: 29934525 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.